Template:Thrombolysis Submassive PE Trials: Difference between revisions
No edit summary |
|||
| (5 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
===[[ | ===[[Thrombolytics for pulmonary embolism]]=== | ||
*Clinical Page | |||
*[[EBQ: PEITHO Trial|PEITHO Trial]] | **[[Thrombolysis for PE]] | ||
*[[EBQ: TOPCOAT Trial|TOPCOAT Trial]] | *Research summary page: [[EBQ:Thrombolysis in Pulmonary Embolism Metanalysis]] | ||
*[[EBQ:MOPETT Trial|MOPETT Trial]] | **[[EBQ: PEITHO Trial|PEITHO Trial]] | ||
**[[EBQ: TOPCOAT Trial|TOPCOAT Trial]] | |||
**[[EBQ:MOPETT Trial|MOPETT Trial]] | |||
Latest revision as of 14:24, 11 January 2020
Thrombolytics for pulmonary embolism
- Clinical Page
- Research summary page: EBQ:Thrombolysis in Pulmonary Embolism Metanalysis
